Lin J - Search Results

1

Clinicopathologic significance and prognostic value of Ki-67 expression in patients with gastric cancer: a meta-analysis.

Luo G, Hu Y, Zhang Z, Wang P, Luo Z, Lin J, Cheng C, Yang Y. Luo G, et al. Among authors: lin j. Oncotarget. 2017 Jul 25;8(30):50273-50283. doi: 10.18632/oncotarget.17305. Oncotarget. 2017. PMID: 28488584 Free PMC article. Review.

2

Development and external validation of prognostic nomograms for liver disease-free and overall survival in locally advanced rectal cancer with neoadjuvant therapy: a post cohort study based on the FOWARC trial.

Zhou J, Li T, Xiao Y, Lin J, Chen X, Peng S, Huang M, Shi X, Cai L, Huang P, Huang M. Zhou J, et al. Among authors: lin j. Ann Transl Med. 2022 Jun;10(12):694. doi: 10.21037/atm-22-2790. Ann Transl Med. 2022. PMID: 35845530 Free PMC article.

3

Neoadjuvant chemoradiotherapy versus neoadjuvant chemotherapy alone for patients with locally advanced rectal cancer: a propensity-score-matched analysis combined with SEER validation.

Wu J, Huang M, Wu Y, Hong Y, Cai L, He R, Luo Y, Wang P, Huang M, Lin J. Wu J, et al. Among authors: lin j. J Cancer Res Clin Oncol. 2023 Sep;149(11):8897-8912. doi: 10.1007/s00432-023-04779-y. Epub 2023 May 8. J Cancer Res Clin Oncol. 2023. PMID: 37154929 Free PMC article.

4

Clinical atlas of rectal cancer highlights the barriers and insufficient interventions underlying the unfavorable outcomes in older patients.

Zhao Z, Lin J, Chen S, Wang X, Wang H, Xu G, Wang J, Zhou R, Huang Z, Li Y, Zhang Y, Liu X, Wang P, Huang M, Luo Y, Yu H. Zhao Z, et al. Among authors: lin j. Heliyon. 2023 May 5;9(5):e15966. doi: 10.1016/j.heliyon.2023.e15966. eCollection 2023 May. Heliyon. 2023. PMID: 37215849 Free PMC article.

5

Silence of a dependence receptor CSF1R in colorectal cancer cells activates tumor-associated macrophages.

Zhu M, Bai L, Liu X, Peng S, Xie Y, Bai H, Yu H, Wang X, Yuan P, Ma R, Lin J, Wu L, Huang M, Li Y, Luo Y. Zhu M, et al. Among authors: lin j. J Immunother Cancer. 2022 Dec;10(12):e005610. doi: 10.1136/jitc-2022-005610. J Immunother Cancer. 2022. PMID: 36600555 Free PMC article.

6

Current Surveillance After Treatment is Not Sufficient for Patients With Rectal Cancer With Negative Baseline CEA.

Shen D, Wang X, Wang H, Xu G, Xie Y, Zhuang Z, Huang Z, Li J, Lin J, Wang P, Huang M, Luo Y, Yu H. Shen D, et al. Among authors: lin j. J Natl Compr Canc Netw. 2022 Mar 1;20(6):653-662.e3. doi: 10.6004/jnccn.2021.7101. J Natl Compr Canc Netw. 2022. PMID: 35231901

7

The Addition of Preoperative Radiation Is Insufficient for Lateral Pelvic Control in a Subgroup of Patients With Low Locally Advanced Rectal Cancer: A Post Hoc Study of a Randomized Controlled Trial.

Xie Y, Lin J, Wang X, Wang P, Zhuang Z, Zou Q, Cai D, Huang Z, Bai L, Tang G, Huang M, Wang J, Yu H, Luo Y. Xie Y, et al. Among authors: lin j. Dis Colon Rectum. 2021 Nov 1;64(11):1321-1330. doi: 10.1097/DCR.0000000000001935. Dis Colon Rectum. 2021. PMID: 33990500 Clinical Trial.

8

RNA demethylase ALKBH5 promotes colorectal cancer progression by posttranscriptional activation of RAB5A in an m6A-YTHDF2-dependent manner.

Shen D, Lin J, Xie Y, Zhuang Z, Xu G, Peng S, Tang G, Bai L, Zhu M, Zhang Y, Huang Z, Wang P, Liu X, Huang M, Luo Y, Wang X, Yu H. Shen D, et al. Among authors: lin j. Clin Transl Med. 2023 May;13(5):e1279. doi: 10.1002/ctm2.1279. Clin Transl Med. 2023. PMID: 37203239 Free PMC article.

9

Evaluation of transrectal ultrasound-guided tru-cut biopsy as a complementary method for predicting pathological complete response in rectal cancer after neoadjuvant treatment: a phase II prospective and diagnostic trial.

Huang Y, Xie Y, Wang P, Chen Y, Qin S, Li F, Wu Y, Huang M, Hou Z, Cai Y, He X, Lin H, Hu B, Qin Q, Ma T, Tan S, Liao Y, Ke J, Zhang D, Lai S, Jiang Z, Wang H, Xiang J, Cai Z, Wang H, He X, Yang Z, Ren D, Wu X, Hong Y, Huang M, Luo Y, Liu G, Lin J. Huang Y, et al. Among authors: lin j, lin h. Int J Surg. 2024 Feb 9. doi: 10.1097/JS9.0000000000001152. Online ahead of print. Int J Surg. 2024. PMID: 38348893

10

Neoadjuvant chemotherapy is noninferior to chemoradiotherapy for early-onset locally advanced rectal cancer in the FOWARC trial.

Cai J, Lin K, Luo T, Weng J, Liu H, Yuan Z, Wan Z, Han J, Lin J, Liu X, Wang X, Huang M, Luo Y, Yu H. Cai J, et al. Among authors: lin j, lin k. Br J Cancer. 2024 May;130(9):1434-1440. doi: 10.1038/s41416-024-02652-4. Epub 2024 Mar 12. Br J Cancer. 2024. PMID: 38472421 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

38,665 results

Search Page